[Does an effective adjuvant treatment in colorectal cancer exist?]

Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials.

Clinical colorectal cancer·2023

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study.

ESMO open·2021

Treatment patterns for metastatic colorectal cancer in Spain.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020

The burden of cancer in Spain.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2018

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.

European journal of cancer (Oxford, England : 1990)·2018

Hyperprogression as a distinct outcome after immunotherapy.

Cancer treatment reviews·2018

Stickler syndrome type 1: case series and new genetic variants.

Revista clinica espanola·2026

Executive summary of the consensus document for recommendations on the treatment of venous thromboembolism in pregnancy: Consensus document from the Spanish Society of Internal Medicine, the Spanish Society of Medical Radiology, the Spanish Society of Vascular Interventional Radiology and the Spanish Society of Gynecology and Obstetrics 2026.

Revista clinica espanola·2026

Treatment of osteoporosis in clinical practice: When, whom, how, and for how long.

Revista clinica espanola·2026

Metabolic alkalosis and clinical outcomes in acute heart failure: a systematic review and meta-analysis.

Revista clinica espanola·2026

Pulmonary embolism: what does the new AHA/ACC 2026 guide add.

Revista clinica espanola·2026

Training in internal medicine in the age of artificial intelligence.

Revista clinica espanola·2026

Locoregional recurrence after transaxillary robotic thyroidectomy for differentiated thyroid cancer: long-term outcomes in 10,504 patients.

Surgical endoscopy·2026

A multivariable model for treatment duration in nonextraction clear aligner therapy.

American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics·2026

Expanding the scope of platinum-NHC complexes: trans-Pt(II) and Pt(0) architectures for ovarian cancer treatment.

Dalton transactions (Cambridge, England : 2003)·2026

Oral Anticoagulation Monotherapy vs Dual-Pathway Antithrombotic Therapy in Chronic Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

East meets west: resectable gastric cancer treatment in the era of immune checkpoint inhibitors.

Expert opinion on pharmacotherapy·2026

Perspectives on the use of coercion in highly specialised rehabilitation: a focus group study.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Related Experiment Videos

[Does an effective adjuvant treatment in colorectal cancer exist?]

Related Concept Videos

Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials.

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study.

Treatment patterns for metastatic colorectal cancer in Spain.

The burden of cancer in Spain.

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.

Hyperprogression as a distinct outcome after immunotherapy.

Stickler syndrome type 1: case series and new genetic variants.

Treatment of osteoporosis in clinical practice: When, whom, how, and for how long.

Metabolic alkalosis and clinical outcomes in acute heart failure: a systematic review and meta-analysis.

Pulmonary embolism: what does the new AHA/ACC 2026 guide add.

Training in internal medicine in the age of artificial intelligence.

Locoregional recurrence after transaxillary robotic thyroidectomy for differentiated thyroid cancer: long-term outcomes in 10,504 patients.

A multivariable model for treatment duration in nonextraction clear aligner therapy.

Expanding the scope of platinum-NHC complexes: trans-Pt(II) and Pt(0) architectures for ovarian cancer treatment.

Oral Anticoagulation Monotherapy vs Dual-Pathway Antithrombotic Therapy in Chronic Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

East meets west: resectable gastric cancer treatment in the era of immune checkpoint inhibitors.

Perspectives on the use of coercion in highly specialised rehabilitation: a focus group study.

Related Experiment Videos

[Does an effective adjuvant treatment in colorectal cancer exist?]

Related Concept Videos

Related Articles